你目前无法使用部分二次筛选功能
请联系客服开通更多权限和功能!
药品名称 | 批准类型 | 活性成分 | 适应症 | 上市发布公告 | 临床试验快照 | 批准日期 | 申请机构 |
---|---|---|---|---|---|---|---|
Alhemo | Biologics | concizumab-mtci | For routine prophylaxis to prevent bleeding episodes in hemophilia A and B | 2024-12-20 | NOVO NORDISK INC | ||
Alyftrek | NME | vanzacaftor, tezacaftor, and deutivacaftor | To treat cystic fibrosis | 2024-12-20 | VERTEX PHARMS INC | ||
Tryngolza | NME | olezarsen | To treat familial chylomicronemia syndrome | 2024-12-19 | IONIS PHARMS INC | ||
Ensacove | NME | ensartinib | To treat non-small cell lung cancer | 2024-12-18 | XCOVERY | ||
Crenessity | NME | crinecerfont | To treat classic congenital adrenal hyperplasia | Press Release | 2024-12-13 | NEUROCRINE | |
Unloxcyt | NME | cosibelimab-ipdl | To treat cutaneous squamous cell carcinoma | 2024-12-13 | CHECKPOINT THERAPEUTICS INC | ||
Bizengri | Biologics | zenocutuzumab-zbco | To treat non-small cell lung cancer and pancreatic adenocarcinoma | 2024-12-04 | MERUS N.V. | ||
Iomervu | NME | iomeprol | For use as a radiographic contrast agent | 2024-11-27 | BRACCO | ||
Rapiblyk | NME | landiolol | To treat supraventricular tachycardia | 2024-11-22 | AOP ORPHAN | ||
Attruby | NME | acoramidis | To treat cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis | 2024-11-22 | BRIDGEBIO PHARMA | ||
Ziihera | Biologics | zanidatamab-hrii | To treat unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer | 2024-11-20 | JAZZ PHARMS | ||
Revuforj | NME | revumenib | To treat relapsed or refractory acute leukemia | 2024-11-15 | SYNDAX | ||
Orlynvah | NME | sulopenem etzadroxil, probenecid | To treat uncomplicated urinary tract infections (uUTI) | 2024-10-25 | ITERUM THERAPEUTICS US LTD | ||
Vyloy | Biologics | zolbetuximab-clzb | To treat gastric or gastroesophageal junction adenocarcinoma | 2024-10-18 | ASTELLAS | ||
Hympavzi | Biologics | marstacimab-hncq | To prevent or reduce bleeding episodes related to hemophilia A or B | Press Release | 2024-10-11 | PFIZER INC | |
ITOVEBI | NME | inavolisib | To treat locally advanced or metastatic breast cancer | 2024-10-10 | GENENTECH INC | ||
Flyrcado | NME | flurpiridaz F 18 | A radioactive diagnostic drug to evaluate for myocardial ischemia and infarction | 2024-09-27 | GE HLTHCARE | ||
Cobenfy | NME | xanomeline and trospium chloride | To treat schizophrenia | Press Release | 2024-09-26 | BRISTOL-MYERS | |
Aqneursa | NME | levacetylleucine | To treat Niemann-Pick disease type C | Press Release | 2024-09-24 | INTRABIO | |
Miplyffa | NME | arimoclomol | To treat Niemann-Pick disease type C | Press Release | 2024-09-20 | ZEVRA DENMARK |